DENTON COMBS: Open Payments
NPI 1598739294 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 13 payments from 6 companies in 2025. Trend: 2023 $260 · 2024 $260 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
Products named: DUPIXENT, GLASSIA, VOQUEZNA, NEFFY, XIFAXAN.
Industry payments across SD — which companies pay providers there.
